Bragar Eagel & Squire, P.C. Reminds Investors That it is Investigating the Board of Directors of Envision Healthcare Corporation (EVHC) on Behalf of Stockholders

Bragar Eagel & Squire, P.C. reminds investors that the Firm is
investigating potential claims on behalf of Envision Healthcare
Corporation (NYSE: EVHC) stockholders concerning the proposed
acquisition of the company by Kohlberg Kravis Roberts & Co. (KKR & Co.),
a private equity fund.

Our investigation concerns whether Envision’s board of directors failed
to adequately shop the Company and obtain the best possible value for
its stockholders before entering into a definitive agreement with KKR &
Co. Under the terms of the agreement, Envision stockholders will receive
$46.00 per share in cash for each Envision share that they own.

If you own Envision shares, have information, would like to learn more
about these claims, or have any questions concerning this announcement
or your rights or interests with respect to these matters, please
contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com,
or telephone at (212) 355-4648, or by filling
out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating
in commercial and securities litigation. For additional information
concerning our investigation of Envision Healthcare Corporation, please
go to https://bespc.com/envisionhealthcare/.
For additional information about Bragar Eagel & Squire, P.C., please go
to www.bespc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005993/en/